GeneReach Biotechnology Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 68.22 million compared to TWD 235.73 million a year ago.

Revenue was TWD 68.19 million compared to TWD 235.68 million a year ago. Net loss was TWD 37.31 million compared to net income of TWD 99.82 million a year ago. Basic loss per share from continuing operations was TWD 0.648 compared to basic earnings per share from continuing operations of TWD 1.736 a year ago.

Diluted loss per share from continuing operations was TWD 0.648 compared to diluted earnings per share from continuing operations of TWD 1.68 a year ago.